JMS manufactures a range of blood bags, renal dialysis devices. AV fistula needles and wing infusion sets in a wide array of configurations.

Founded in June 1965, the Head Office of JMS Co., Ltd is located in Hiroshima, Japan. JMS has four factories and forty Sales offices in Japan which are efficiently managed and linked by an "on-line" computer network to provide excellent service for the local health care needs. JMS Co., Ltd is a public listed company on the Tokyo Stock Exchange.

Research and development is continually carried out under close collaboration with the Head Office in Japan, on scientific and technical know-how, to keep up with innovation changes.

The JMS Head Office in Tokyo directs the distribution and marketing of JMS products in Japan and directs the activities of the global network of companies.

Being an international company, JMS has manufacturing facilities worldwide in Japan, Korea, Singapore, China, and Indonesia to cater for our customers’ needs globally.

JMS Singapore Pte Ltd or JMS(S) is a wholly-owned subsidiary of JMS Co., Ltd. Established in June 1979 with a paid up capital of S$16.0 million. This is their second JMS overseas project outside Japan to meet world-wide increasing demands for disposable medical products.

In December 1988, a USD 9.3 million 4-storey modern plant extension was completed to double the built-in area to 13,499 sq. meters to achieve rapid growth in international business. In June 1994, JMS expanded further by establishing a wholly owned subsidiary in Batam, Indonesia.

The production plant is fully equipped with in-house facilities that rely upon advance engineering and state of the art manufacturing technology. As a pioneer in disposable medical equipment, the JMS Group of Companies shares a common vision to be "The Bridge to Good Health Care", dedicated to progressive health care by setting high standards for our scientific personnel and production technology to satisfy users of the systems they produce.

Placing themselves in the position of their customers and safeguarding the lives of patients has been, and will continue to be, their goal to meet the challenges presented by the new frontiers of medical technology and healthcare issues.